This study was approved by the ethics committee of our institution. Liver tissue was obtained from a Ministry of Health-approved hospital tissue bank (Table 1). ADHLSCs were obtained after primary culture of the parenchymal fraction cells, as previously described [14 (link), 17 (link)]. The supernatant, containing the non-parenchymal cell fraction, was processed by Nycodenz gradient (Myegaard, Oslo, Norway) centrifugation to isolate HSCs [26 (link)]. Both cell types were cultured in Dulbecco’s modified Eagle’s medium (DMEM) containing 4.5 g/L glucose (Life Technologies, Carlsbad, CA, USA) supplemented with 10% fetal calf serum (FCS; Life Technologies) and 1% penicillin/streptomycin (Life Technologies), at 37 °C in a humidified atmosphere containing 5% CO2, as previously described [17 (link)]. When the cells reached 80% confluence, they were detached by treatment with 0.05% Trypsin-EDTA (Life Technologies). The viability of the recovered cells was evaluated using the trypan blue exclusion assay.

Characteristics of the four liver donors whose samples were used for the isolation of HSCs and ADHLSCs used in the current study

Donor numberAgeGenderCause of deathBlood groupIschemia time
893 daysMRespiratoryA+4 h
932 yearsFMetabolic disease (liver transplanted)O+1 h 43 min
987 daysMCardio-respiratory arrestO-4 h 20 min
10546 yearsFTraumaB+9 h 43 min
Free full text: Click here